Location: Home
  • search
  • go
  • Relate News
  • 5/18/2021Milestone and Ji Xing Pharma Ink $127M Etripamil Development Agreement...
  • 5/18/2021LianBio Partners With Landos to Commercialize Colitis, Crohn's Drugs i...
  • 5/18/2021Roche Inaugurates In-house Accelerator in Shanghai Zhangjiang
  • 5/18/2021WuXi Bio Steps Up Its ADC Manufacturing Game with A New, Dedicated Sub...
  • 5/18/2021China Overhauls Its Public Health Administration with Newly Created NA...
  • 5/18/2021Kinnate, OrbiMed Forms JV for Chinese Lung Cancer Market
  • 5/17/2021CDE Publicizes the List of Reference Formulations for GQCE Studies (43...
  • 5/17/2021State Council Approves Cross-border Retail e-Commerce Trial for Import...
  • 5/17/2021China Indicates Support of IP Waiver for Coronavirus Vaccines
  • 5/17/2021Everest Med's BLA for Sacituzumab Govitecan-Hziy Accepted in China 
  • 5/17/2021Iconovo Extends Deal with Amneal for Generic Symbicort to Cover Key Ma...
  • 5/17/2021Lilly/Innovent File U.S. BLA for Sintilimab in Combo with Pemetrexed a...
  • 5/14/2021Reuters: Kintor's COVID-19 Drug Claims Trigger Skepticism
  • 5/14/2021Pregene and Dr. Reddy's Announce License Agreement for Anti-BCMA CAR-T...
  • 5/14/2021Antengene Announces the IND Approval for Eltanexor in Patients with Ad...
  • 5/14/2021CDE Solicits Comments on the Guidelines for Clinical Trial of Therapeu...
  • 5/14/2021CDE Solicits Comments on the Guidelines for Writing Relevant Pediatric...
  • 5/14/2021PharmaDJ's China Market Approval Tracker: March 2021
  • 5/13/2021Antengene Granted Chinese IND Approval for a Global PIII Trial of Sel...
  • 5/13/2021China Inaugurates State Administration of Disease Prevention and Contr...
  • 5/13/2021NMPA Issues the Guidelines for Pharmacovigilance Quality Control
  • 5/13/2021NHC Issues the 2021 Edition of Diagnostic and Therapeutic Guidelines f...
  • 5/12/2021GlobalData: New Chinese Breakthrough Therapy Designation Attracts Fore...
  • 5/12/2021CDE Solicits Comments on the Guidelines for Clinical Trial Protocol De...
  • 5/12/2021IQVIA: Chinese Hospital Drug Market Down 10.7% in 2020
  • 5/12/2021Citrine and Diurnal Enter Partnership to Pring Efmody to China for...
  • 5/12/2021Pharma e-Commerce Operator Beijing Yuanxin Eyes HK IPO
  • 5/11/2021Sumitomo Dainippon and Sinovant Enter License Pact for Select Asian Pr...
  • 5/11/2021Shanghai-based Alebund Pharma Raises $60M in Series B Financing Round
  • 5/11/2021AmCham White Paper Calls on China to Play Fair
  • Page:224/812 Total number of articles:24346: [First][<<] [222] [223] [224] [225] [226] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group